222 related articles for article (PubMed ID: 21680901)
1. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.
Meloche J; Paulin R; Courboulin A; Lambert C; Barrier M; Bonnet P; Bisserier M; Roy M; Sussman MA; Agharazii M; Bonnet S
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2114-24. PubMed ID: 21680901
[TBL] [Abstract][Full Text] [Related]
2. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.
Paulin R; Courboulin A; Meloche J; Mainguy V; Dumas de la Roque E; Saksouk N; Côté J; Provencher S; Sussman MA; Bonnet S
Circulation; 2011 Mar; 123(11):1205-15. PubMed ID: 21382889
[TBL] [Abstract][Full Text] [Related]
3. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
5. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Lampron MC; Vitry G; Nadeau V; Grobs Y; Paradis R; Samson N; Tremblay È; Boucherat O; Meloche J; Bonnet S; Provencher S; Potus F; Paulin R
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):783-801. PubMed ID: 31969012
[TBL] [Abstract][Full Text] [Related]
6. Opposing roles of RAGE and Myd88 signaling in extensive liver resection.
Zeng S; Zhang QY; Huang J; Vedantham S; Rosario R; Ananthakrishnan R; Yan SF; Ramasamy R; DeMatteo RP; Emond JC; Friedman RA; Schmidt AM
FASEB J; 2012 Feb; 26(2):882-93. PubMed ID: 22075646
[TBL] [Abstract][Full Text] [Related]
7. RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity.
Yu W; Liu-Bryan R; Stevens S; Damanahalli JK; Terkeltaub R
Atherosclerosis; 2012 Jun; 222(2):417-25. PubMed ID: 22552116
[TBL] [Abstract][Full Text] [Related]
8. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells.
Maltais JS; Simard E; Froehlich U; Denault JB; Gendron L; Grandbois M
Pharmacol Res; 2016 Feb; 104():176-85. PubMed ID: 26707030
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
Courboulin A; Barrier M; Perreault T; Bonnet P; Tremblay VL; Paulin R; Tremblay E; Lambert C; Jacob MH; Bonnet SN; Provencher S; Bonnet S
Eur Respir J; 2012 Sep; 40(3):618-29. PubMed ID: 22496325
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression.
Jang EJ; Baek SE; Kim EJ; Park SY; Kim CD
Vascul Pharmacol; 2019; 118-119():106559. PubMed ID: 30954689
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion.
Zhai Y; Morihara R; Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Yu H; Sun H; Takemoto M; Nakano Y; Yunoki T; Tang Y; Ishiura H; Yamashita T
Brain Res; 2024 Apr; 1828():148790. PubMed ID: 38272156
[TBL] [Abstract][Full Text] [Related]
12. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
13. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
14. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis.
Bonnet S; Paulin R; Sutendra G; Dromparis P; Roy M; Watson KO; Nagendran J; Haromy A; Dyck JR; Michelakis ED
Circulation; 2009 Sep; 120(13):1231-40. PubMed ID: 19752325
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
17. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
[TBL] [Abstract][Full Text] [Related]
18. Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function.
Simard E; Söllradl T; Maltais JS; Boucher J; D'Orléans-Juste P; Grandbois M
PLoS One; 2015; 10(8):e0128881. PubMed ID: 26248341
[TBL] [Abstract][Full Text] [Related]
19. Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA.
Sun J; Zheng J; Ling KH; Zhao K; Xie Z; Li B; Wang T; Zhu Z; Patel AN; Min W; Liu K; Zheng X
J Transl Med; 2012 Jan; 10():2. PubMed ID: 22216901
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.
Yu H; Sliedregt-Bol K; Overkleeft H; van der Marel GA; van Berkel TJ; Biessen EA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1531-7. PubMed ID: 16675727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
